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Summary
Objectives: To isolate and characterize an asparaginyl endopeptidase from the carcinogenic liver
fluke, Opisthorchis viverrini, and evaluate its expression profile, biochemical activity, and
potential as an immunodiagnostic antigen.
Methods: The full length mRNA encoding an asparaginyl endopeptidase (family C13), Ov-aep-1,
was isolated by immunoscreening of a cDNA bacteriophage library of adult O. viverrini using sera
from patients infected with O. viverrini. Investigation of Ov-aep-1 transcripts in developmental
stages of the parasite, and phylogenetic analysis, immunohistochemical localization, and
recombinant protein expression and enzymology were employed to characterize the Ov-AEP-1
protein. Immunoblotting was used to assess the potential of this enzyme for immunodiagnosis of
human opisthorchiasis.
Results: Ov-AEP-1 is characteristic of the C13 cysteine protease family. Ov-aep-1 transcripts
were detected in adult and juvenile worms, eggs, and metacercariae. Phylogenetic analysis
indicated that Ov-AEP-1 is closely related to homologous proteins in other trematodes. Recom-
binant Ov-AEP-1 was expressed in bacteria in inclusion bodies and refolded to a soluble form.
Excretory—secretory (ES) products derived from adult O. viverrini and refolded recombinant Ov-
AEP-1 both displayed catalytic activity against the diagnostic tripeptide substrate, Ala—Ala—Asn-
aminomethylcoumarin. Rabbit antiserum raised to recombinant Ov-AEP-1 identified the native
AEP-1 protease in both somatic extract and ES products of adult worms. Anti-Ov-AEP-1 IgG* Corresponding author. Tel.: +66 43 348 387; fax: +66 43 202475.
E-mail address: thewa_la@kku.ac.th (T. Laha).
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immunolocalized the anatomical site of expression to the gut of the fluke, implying a physio-
logical role in digestion of food or activation of other digestive enzymes. Recombinant Ov-AEP-1
was recognized by serum antibodies from patients with opisthorchiasis but not other helminth
infections, with a sensitivity and specificity of 85% and 100%, respectively. The positive and
negative predictive values are 100% and 67%, respectively.
Conclusions: The liver fluke, O. viverrini, has a gut-localized asparaginyl endopeptidase.
Refolded recombinant Ov-AEP-1 is catalytically active and has potential for immunodiagnosis
of human opisthorchiasis.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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The liver fluke, Opisthorchis viverrini, is an important human
pathogen endemic in Southeast Asia, predominantly North-
east Thailand.1 Infection with this parasite causes
opisthorchiasis, which is associated with a number of hepa-
tobiliary abnormalities, including cholangitis, obstructive
jaundice, hepatomegaly, cholecystitis, and cholelithiasis.2
Experimental and epidemiological evidence strongly impli-
cates O. viverrini infection in the etiology of cholangiocar-
cinoma, cancer of the bile ducts.1,3—5 Indeed, O. viverrini is
the only metazoan pathogen that is considered a class I
carcinogen.4 It has been implied that inflammation of the
bile ducts caused by O. viverrini infection and induction of
endogenous nitric oxide are important factors for carcino-
genesis.6,7 Moreover, cell proliferation induced by O. viver-
rini and exposure to exogenous carcinogens such as nitrates,
nitrites, and even N-nitroso compounds found in several
fermented or preserved foods have been implicated as fac-
tors involved with parasite-associated neoplastic processes.1
O. viverrini infection induces several pathological changes
including epithelial desquamation, epithelial and adenoma-
tous hyperplasia, goblet cell metaplasia, inflammation, peri-
ductal fibrosis, and granuloma formation.8 The pathogenesis
ofO. viverrini-mediated hepatobiliary changesmay be due to
mechanical irritation caused by the liver fluke suckers and/or
its excretory—secretory (ES) products.2,9,10
Proteolytic enzymes are major components of helminth ES
products, where they play essential roles in digestion of food
proteins, immunomodulation, and host tissue invasion.11
Asparaginyl endopeptidases are cysteine proteases (MEROPS
clan CD, family C13) that hydrolyze peptides and proteins on
the carboxyl side of asparagine residues. These enzymes are
often referred to as ‘legumain-like’ in reference to the first
member of the family that was described from beans. Legu-
mains were then discovered in Schistosoma mansoni12,13 and
later reported from other parasitic helminths including Fas-
ciola spp14,15 and Haemonchus contortus.16 Schistosome
asparaginyl endopeptidases (AEPs) are expressed in the gas-
trodermis where they may trans-activate other proteases
including the papain-like cathepsin B cysteine protease,
SmCB1.17,18 Prior to the first reports of genes encoding plant
legumains, the S. mansoni AEP was called Sm32, and was of
interest due to its potential as a serodiagnostic antigen for
schistosomiasis.19
In this report, we describe the identification of a cDNA
encoding asparaginyl endopeptidase from O. viverrini and its
expression in the gut of adult worms and in eggs. We also
describe the preparation and purification of a recombinantform of the protease and investigation of its potential as a
serodiagnostic antigen for human opisthorchiasis.
Materials and methods
Immunoscreening of an adult Opisthorchis
viverrini cDNA library
A cDNA library of adult O. viverrini was constructed using the
SMARTTM library construction kit (Clontech, Mountain View,
CA, USA) as described elsewhere.20 Immunoscreening of the
cDNA library was performed with the picoBlueTM immuno-
screening kit in accordance with the manufacturer’s instruc-
tions (Stratagene, La Jolla, CA, USA). Membranes were
probed with a pool of sera from people infected with O.
viverrini and diagnosed with cholangiocarcinoma. Moreover,
these sera were pooled from samples exhibiting elevated
antibody titers against ES antigen, as previously described.21
Sera used in this study were obtained with the approval of the
Ethics Committee of Khon Kaen University (HE451132). Posi-
tive phage plaques were selected for conversion to phage-
mids. Nucleotide sequences of the immuno-positive
recombinant clones were analyzed using standard automated
sequencing methodologies. Sequences were edited and
translated to deduced amino acid sequences using BioEdit.22
Homology searches were performed using Blast search at
NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Open read-
ing frames (ORFs) were further analyzed for signal peptides/
anchors using SignalP-NN prediction and SignalP-HMM pre-
diction at http://www.cbs.dtu.dk/services/SignalP/.
Phylogenetic analysis
The phylogenetic relationship between Ov-AEP-1, Ov-AEP-2,
and other AEPs was analyzed based on amino acid sequence.
The full length ORFs of the Ov-AEPs were aligned with AEPs
from other species using ClustalW.23 A phylogenetic tree was
constructed with distance matrix using the neighbor-joining
method with 1000 bootstrap samplings in Phylip software
package version 3.6.3.
Reverse transcription PCR
Reverse transcription (RT)-PCR was used to evaluate devel-
opmental expression of Ov-aep-1 in life cycle stages of O.
viverrini. cDNAs of adult, juvenile, egg, and metacercariae
were prepared from fresh sample or samples stored in RNA-
later (Ambion, Foster city, CA, USA) using Nucleospin1 RNA II
Asparaginyl endopeptidase from Opisthorchis viverrini e51(Macherey-Nagel, Du¨ren, Germany). RT-PCR was carried out
using a Robust II RT-PCR kit (Finnzymes, Espoo, Finland). Ov-
aep-1-specific primers (50-GGGCAAGGTGTTCAATGACT for the
forward primer and 50-CAAGTGCCAATGATTGTGTC for the
reverse primer) were designed to span nucleotides 286—
720 (the active site His and Cys residues in the ORF) and
amplify a 433-bp target. PCR was performed with Taq poly-
merase (Invitrogen, Carlsbad, CA, USA) with 35 cycles of
94 8C for 1 min, 55 8C for 1 min, 72 8C for 2 min, followed
by a final extension at 72 8C for 10 min. A positive control
targetingO. viverrini actin, a constitutively expressed house-
keeping gene, and a negative control in which reverse tran-
scriptase was substituted with water were included. PCR
products were analyzed by 0.8% agarose gel electrophoresis.
Production and purification of recombinant
Ov-AEP-1
The entire ORF of Ov-AEP-1 minus the predicted signal pep-
tide was amplified by PCR using oligonucleotide primers:
forward primer: 50-ACGCGCGCTCGAGGCATGGTTAGGCGCT-
GTT; reverse primer: 50-ACGGCGCC CTCGAGCTAGGAACA-
GACTTCATGAAC. Primers contained Xho I and Nde I sites
(underlined), respectively, to facilitate ligation into the
expression plasmid, pET-15b (Novagen, Madison, WI, USA).
PCR products were gel purified (Qiagen, Hilden, Germany),
ligated into pGEM-T (Promega, Madison, WI, USA), and the
ligation products employed to transform Escherichia coli
strain JM109 (Promega, Madison, WI, USA). Recombinant
plasmids were purified using a kit (Qiagen, Hilden, Germany),
after which they were digested with Xho I and Nde I. The
excised fragments were separated through 1% agarose and
purified by gel extraction. The inserts were then cloned into
the Xho I and Nde I sites of pET-15b that had been linearized
with these enzymes. The resulting plasmid was designated
pOVAEP1. The insert sizes of plasmids were confirmed by
restriction digestion and PCR using the T7 promoter primer
and the gene-specific reverse primer. Plasmids were
sequenced using the T7 primer to confirm their identity
and in-frame fusion to the hexaHis-tag encoded by the
pET15b vector.
The recombinant protein was expressed in E. coli strain
BL21(DE3) (Novagen Madison, WI, USA). E. coli strain
BL21(DE3) were transformed with pOVLGM1 by heat shock
at 42 8C after which transformed cells were plated on LB agar
supplemented with ampicillin (50 mg/ml) and incubated at
37 8C overnight. Single colonies were picked and cultured in
100 ml LB medium with ampicillin (50 mg/ml) at 37 8C until
the OD600 reached 0.6. Recombinant protein expression was
induced by addition of isopropyl b-D-1-thiogalactopyranoside
(IPTG) to 1 mM final concentration for 3 h at 37 8C with
shaking at 300 rpm. To purify the recombinant protein, cells
were chilled on ice and collected by centrifugation at 5000 g
for 15 min at 4 8C. Cells were then resuspended in 10 ml of
binding buffer (5 mM imidazole, 0.5 M NaCl, 20 mM Tris—HCl,
pH 7.9), and then lysed by freeze/thawing two times fol-
lowed by sonication (25 amps, 5 s burst and 5 s rest, for 5 min)
at 4 8C. The lysates were clarified by centrifugation as
described above and supernatants collected. Lysed cells were
also resuspended in 10 ml of binding buffer containing 8 M
urea and sonicated again. The supernatants (both denatured
and non-denatured) containing recombinant proteins werepurified by affinity chromatography using His-Trap FF nickel
columns (GE Healthcare Bio-Sciences, Piscataway, NJ, USA)
fitted to a liquid chromatography system (AKTA Prime, GE
Healthcare, Piscataway, NJ, USA). The recombinant hexaHis-
tagged proteins were eluted with a 10—50 mM imidazole
gradient in binding buffer, with or without 8 M urea. Protein
purity was evaluated at various stages of purification by
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and staining of gels with Coomassie Brilliant Blue
and/or Western blotting using an anti-hexaHis-Tag antibody
(Invitrogen, Carlsbad, CA, USA).
Refolding of denatured Ov-AEP-1
Fractions containing hexaHis-tagged Ov-AEP-1 were pooled
and processed for refolding. To obtain bioactive recombinant
protein, the protein isolated in its denatured form was
refolded by stepwise dialysis (1 M urea increments every
24 h) against phosphate buffered saline (PBS), pH 7.4. After
removal of urea the refolded protein was concentrated
(Eppendorf concentrator 5301) to approximately 0.3 mg/
ml. The protein concentration was determined by absor-
bance at 280 nm and fractions were analyzed by SDS-PAGE.
Production and assessment of anti-Ov-AEP-1
rabbit antiserum and purification of IgG
Antiserum against affinity-purifiedOv-AEP-1 was produced by
immunization of a male New Zealand White rabbit. Before
immunization, pre-immune serumwas collected (10 ml) from
blood taken from the ear vein. For the first injection, 1.0 mg
of refolded recombinant Ov-AEP-1 was emulsified in an equal
volume of Freund’s complete adjuvant and injected subcu-
taneously with equal volumes being administered to the
buttock, neck, and fore leg. The immunization was repeated
twomore times at 14-day intervals using Freund’s incomplete
adjuvant to emulsify the recombinant Ov-AEP-1. The rabbit
was bled from the ear vein two weeks after the final immu-
nization and the serum IgG titer was determined against
purified recombinant Ov-AEP-1 protein by enzyme-linked
immunosorbent assay (ELISA) using standard protocols.21
Western blotting was also performed to evaluate the recog-
nition of recombinant Ov-AEP-1 and the native protein in
parasite extracts from different developmental stages of O.
viverrini. Parasite extracts were obtained as described.10,24
Recombinant protein was transferred to nitrocellulose mem-
brane using a Mini Trans Blot electrode (Bio-Rad, Hercules,
CA, USA). Membranes were blocked overnight at 4 8C or room
temperature for 1 h in PBS containing 0.03% Tween 20 (PBS/
T) and 5% non-fat milk powder in PBS/T (blocking buffer).
Membranes were probed for 1 h with primary antibody (rab-
bit anti-Ov-AEP-1 serum diluted 1:100 in 2% non-fat milk
powder in PBS/T) at room temperature. Horseradish perox-
idase (HRP)-labeled goat anti-rabbit antibody (Invitrogen
Carlsbad, CA, USA) diluted 1:2000 in antibody buffer was
applied and the membrane was incubated for 1 h at room
temperature. Following removal of the secondary antibody
solution, the membrane was washed 3  10 min in PBS/T,
then incubated in chemiluminescence substrate (ECL, Amer-
sham Biosciences, USA). Signals were detected using X-ray
film (Kodak, USA).
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A sepharoseTM CL-4B (Zymed, USA), eluted from the resin in
glycine pH 3.0, and neutralized in Tris pH 8.0. Concentration
of eluted IgG was determined spectrophotometrically at OD
280 nm.
Assessment of recombinant Ov-AEP-1 and
Opisthorchis viverrini ES products for AEP
activity
Refolded Ov-AEP-1 and ES products of adult O. viverrini (ES
products prepared as described previously24) were analyzed
for asparaginyl endopeptidase activity using the fluorogenic
tripeptide substrate, Z-Ala—Ala—Asn-aminomethylcou-
marin (Sigma-Aldrich, St. Louis, MO, USA).25 Release of
aminomethylcoumarin from hydrolyzed substrate was mea-
sured in a fluorescence spectrometer (FLUOstar, BMG Lab-
tech, Offenburg, Germany). The pH optima for cleavage of
O. viverrini ES products and recombinant Ov-AEP-1 were
determined by incubating the proteins with substrate at
37 8C for up to 12 h in buffers ranging from pH 3.0 to 8.0
with increments of 0.5 pH units (0.1 M sodium acetate, pH
3.0—6.0; 0.1 M sodium phosphate, pH 6.5—7.5; 0.1 M Tris—
HCl, pH 8.0). The final substrate concentration was main-
tained at 5.0 mM. Catalytic activity was expressed as rela-
tive fluorescence units. Iodoacetamide at 5 mM final
concentration was included in some reactions as an inhibitor
of AEP activity.26
Immunolocalization
Adult O. viverrini recovered from infected hamsters, as well
as adult worms in situ in hamster bile ducts, were mounted in
paraffin (Sakura Tissue-Tek1 TECTM) and sectioned as
described.9 The sections were deparaffinized in xylene three
times for 5 min each. After deparaffinization, slides were
dehydrated in decreasing concentrations of ethanol; abso-
lute ethanol three times, 5 min each, 95% ethanol two times,
3 min each, 70% ethanol one time, 3 min, and a final rinse
with tap water for 1—2 min. Slides were then washed in PBS
twice, 5 min each, then rinsed with tap water for 5 min.
Slides were exposed to 30% H2O2 in methanol for 30 min to
block non-specific endogenous peroxidase activity. Sections
were then blocked for non-specific binding with normal horse
serum diluted 1:20 in PBS/NaN3 for 30 min at room tempera-
ture in a humid chamber. The parasite sections were probed
with anti-Ov-AEP-1 IgG or pre-immunization IgG from the
same rabbit at a dilution of 1:100 in PBS/NaN3 in a humid
chamber at 4 8C overnight. Sections were then incubated in
secondary antibody (HRP-goat anti-rabbit IgG) diluted 1:200
in PBS for 1 h at room temperature. To develop color, slides
were submerged in freshly prepared DAB solution for 5 min,
after which the reaction was stopped with tap water and
slides counterstained with Mayer hematoxylin for 1 min. The
slides were washed with tap water and dehydrated as fol-
lows: 70% alcohol once for 3 min; 95% alcohol twice, 3 min
each; final dehydration in absolute alcohol three times, 3 min
each. Slides were then examined and photographed with the
aid of 10 and 20 objectives fitted to an Olympus model
BX40 compound microscope connected with a digital camera
(Nikon DXA1200C).Serologic recognition of Ov-AEP-1 by sera from
human opisthorchiasis cases
An immunoblot assay was developed to identify anti-Ov-AEP-
1 serum antibodies in patients with active O. viverrini infec-
tion. Recombinant Ov-AEP-1 was resuspended in denaturing/
reducing sample buffer, boiled for 5 min, and electrophor-
esed on a 15% SDS-PAGE gel. The proteins were transblotted
onto nitrocellulose membrane by a semi-dry system (Bio-
Rad). The membrane was then cut into strips, each strip
containing 4 mg recombinant fusion protein. The strips were
washedwith PBST for 5 min then blocked for 1 hwith blocking
buffer. Strips were then incubated with sera from patients
infected with diverse helminth parasites, including Taenia
spp tapeworms, minute intestinal flukes (lecithodendrids),
hookworm, Echinostoma spp, and O. viverrini. These human
sera were collected individually from several areas of North-
east Thailand according to an approved protocol (Khon Kaen
University Institutional Review Board No. HE500119). Positive
infection was diagnosed based on detection of eggs from
fecal examinations using the formalin—ethyl acetate con-
centration technique. Sera from four individuals from an
urban area of the province of Khon Kaen (and one pooled
sample) who were determined to be free of helminth infec-
tions after fecal examination, and were negative for anti-
bodies toO. viverrini ES antigens as described,21,24 were used
as negative controls. All human sera were diluted 1:50 in 2%
skim milk in PBST buffer and incubated at room temperature
for 2 h with shaking. Strips were washed with PBST five times
for 5 min each followed by incubation for 2 h with HRP-goat
anti-human IgG diluted 1:1000 in antibody buffer. The strips
were washed again with PBST five times for 5 min each and
color reactions were developed by the addition of 3,30-dia-
minobenzidine (DAB) substrate.
Results
At least two mRNAs encoding asparaginyl
endopeptidases are present in the Opisthorchis
viverrini transcriptome
The full-length mRNA sequence encoding an AEP was isolated
by immunoscreening an O. viverrini cDNA library with a pool
of sera from patients with both O. viverrini infection and
cholangiocarcinoma. The original clone isolated from the
library was designated Ov-aep-1. The Ov-aep-1 cDNA com-
prised 1302 bp, encoding a deduced protein of 408 amino
acids with predicted molecular mass of 47 kDa. The sequence
of Ov-aep-1 has been assigned GenBank accession number
DQ402101. For recombinant protein expression, specific
primers flanking the entire ORF (minus signal peptide) were
designed to amplify the ORF of Ov-aep-1 by PCR using the
cDNA library as template. The resulting amplicon was sub-
sequently cloned into pET15b. During this sub-cloning stage,
a second (larger) amplicon was generated by PCR. The ORF of
this second cDNAwas 95% identical to Ov-AEP-1, with most of
the difference being due to a unique insertion of 25 amino
acids near the C-terminus. This clone was designated Ov-aep-
2. Ov-AEP-1 had a predicted signal peptide with a cleavage
site between residues 17 and 18 (Figure 1). We did not obtain
the full-length 50 sequence of Ov-aep-2 so the presence of a
Figure 1 Multiple sequence alignment of Ov-AEP-1 with other members of the clan CD, C13 peptidase family. Identical residues in
more than 50% of sequences are in black boxes; conserved substitutions are in gray boxes. The conserved active site histidine and
cysteine residues are highlighted. The putative N-glycosylation sites are shown on the top of the alignments.
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and Ov-AEP-2 exhibited the conserved residues of AEPs
(Figure 1). Two potential N-linked glycosylation sites (NXS/
T) were detected in both Ov-AEP-1 and Ov-AEP-2 at Asn-68
and Asn-173 (AEP-1 numbering scheme) (Figure 1).
Opisthorchis viverrini asparaginyl endopeptidase
closely related to asparaginyl endopeptidase
from platyhelminths
The amino acid sequence of Ov-AEP-1 was compared to AEPs
from other eukaryotes including platyhelminths, nematodes,
plants, and vertebrates. Multiple sequence alignments usedFigure 2 Neighbor-joining phylogenetic tree showing the evoluti
animals and flowering plants. Numbers on branches refer to bootstrap
accession numbers of legumain sequences used in the phylogene
ABQ02437 (Fasciola gigantica), CAC85636 (Fasciola hepatica), P09
CAB01126 (Caenorhabditis elegans), CAE75506 (Caenorhabditis br
mum), AAM60827 (Arabidopsis), CAA04439 (mouse), AAH87708 (ra
AAH56842 (Xenopus), CAG13252 (Tetraodon), and AAS94231 (Ixodto construct the phylogenetic tree revealed complete con-
servation of the active site His and Cys residues through these
divergent species. The neighbor-joining phylogenetic tree
showed that Ov-AEP-1 formed a highly robust clade (100%
bootstrap support) with AEPs from other flukes, particularly
the closely related Fasciola and Schistosoma species
(Figure 2). Other members of the C13 family formed clades
mostly on a taxonomic basis; distinct and strongly supported
clades were formed by nematodes, plants, and vertebrates.
One exception was AEP from the tick, Ixodes ricinus (Gen-
Bank accession number AAS94231) (Arthropoda), which
formed a very robust clade (99.9% bootstrap support) with
vertebrate AEPs.onary relationship of Ov-AEP-1 with other C13 peptidases from
values; the scale bar at the bottom represents 100 changes. The
tic analysis are as follows: ABD64147 (Opisthorchis viverrini),
841 (Schistosoma mansoni), P42665 (Schistosoma japonicum),
iggsae), CAJ45481 (Haemonchus contortus), AAF89679 (Sesa-
t), CAG33687 (human), AAI11118 (cow), XP_421328 (chicken),
es ricinus; tick).
Figure 3 Expression of Ov-aep-1 in developmental stages of O.
viverrini, as determined by RT-PCR. The following cDNA tem-
plates were included: lane 1, egg; lane 2, metacercaria; lane 3,
juvenile worm; lane 4, adult worm; lane 5, adult worm cDNA
library. The lower panel shows expression of the actin mRNA in
the developmental stages, included here as a constitutively
expressed control transcript.
Figure 5 Western blot of recombinant Ov-AEP-1 (rAEP-1),
crude somatic (SA), and excretory/secretory (ES) antigens of
adult Opisthorchis viverrini probed with purified IgG from the
serum of a rabbit immunized with rAEP-1 (a-rAEP-1) or normal
rabbit serum (NRS).
Figure 4 Affinity purification of recombinant Ov-AEP-1
expressed in Escherichia coli as assessed by Coomassie Blue
stained SDS-PAGE gel. Lane 1, uninduced E. coli cell pellet; lane
2, IPTG-induced cell pellet; lane 3, supernatant from pellet
solubilized in binding buffer; lane 4, supernatant from pellet
solubilized in 8 M urea in binding buffer; lane 5, affinity-purified
Ov-AEP-1 in 6 M urea; lane 6, equal loading of refolded purified
recombinant Ov-AEP-1 in PBS buffer; lane 7, immunoblot of
recombinant Ov-AEP-1 protein probed with anti-hexaHis-tag
antibody.
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stages of the liver fluke
The expression pattern of the Ov-aep-1 mRNA in develop-
mental stages of O. viverrini was investigated by RT-PCR.
Amplicons were detected in RNA from egg, metacercaria,
juvenile worm, and adult worm (Figure 3A). The actin mRNA
was constitutively expressed in all these stages, constituting
a control for cDNA integrity and PCR fidelity (Figure 3B). No
amplicons were detected in the negative controls where
water replaced template DNA or where water was substi-
tuted for reverse transcriptase.
Recombinant Ov-AEP-1 recovered from inclusion
bodies
The cDNA encoding the ORF of Ov-aep-1 was amplified by
PCR from the O. viverrini library, cloned into bacterial
expression plasmid pET-15b, and its identity was confirmed
by sequencing. Recombinant Ov-AEP-1 (rAEP-1) was pro-
duced in E. coli BL21(DE3) as a crystalline fusion protein
that was dissolved in denatured form in 6 M urea in order to
recover the protease (Figure 4). The expressed enzyme
migrated as a single band in SDS-PAGE of 47 kDa, in agree-
ment with theoretical mass predictions. The urea-dena-
tured rAEP-1 was refolded into PBS to yield a soluble
product with approximately 0.3 mg/ml (10% recovery).
The purified denatured and refolded recombinant proteins
were both recognized on immunoblots by anti-hexaHis
monoclonal antibody (Figure 4), confirming their identities
as Ov-AEP-1.
Ov-AEP-1 is secreted by adult Opisthorchis
viverrini liver flukes
IgG purified from serum from a rabbit immunized with rAEP-1
recognized the recombinant immunogen in Western blot
analysis. By contrast, control IgG from the preimmunization
rabbit serum did not bind to rAEP-1 (not shown). Anti-rAEP-1
IgG also recognized an antigen of the expected size,47 kDa,
in soluble parasite extracts and in ES products of adult O.
viverrini; the control IgG did not bind to proteins of this size
(Figure 5).Detection of AEP catalytic activity in refolded
recombinant Ov-AEP-1 and Opisthorchis
viverrini ES products
Catalytic activity against the diagnostic substrate Z-Ala—
Ala—Asn- aminomethylcoumarin was detected in 0.2 mg of
O. viverrini ES products with an optimal pH of 7.0 (Figure 6).
Activity was not detected below pH 6.0 (not shown). The
activity was completely inhibited in the presence of 5 mM
iodoacetamide (not shown). Cleavage of Z-Ala—Ala—Asn-
aminomethylcoumarin was also detected with 2.0 mg of
rAEP-1 (Figure 6), and this was inhibited completely by
iodoacetamide (not shown). However, the specific activity
of rAEP-1 was lower than that detected for ES products. Ten-
fold less total protein was added to the reaction with ES
products (compared to rAEP-1), and moreover, Ov-AEP-1 is
only one of many proteins in ES products (J. Mulvenna and A.
Loukas, unpublished), indicating that the majority of reso-
lubilized rAEP-1 had not adopted proper conformation, and
therefore, only a small proportion of this preparation dis-
played catalytic activity. Alternatively, all of the refolded
material had adopted the same conformation but this was not
Figure 6 Hydrolysis of the fluorogenic peptide Z-Ala—Ala—Asn-
aminomethylcoumarin by Opisthorchis viverrini excretory—
secretory (ES) products and recombinant Ov-AEP-1 as measured
by an increase in relative fluorescence due to release of Z-Ala—
Ala—Asn-aminomethylcoumarin over time. The assay was per-
formed at pH 7. 0. Inclusion of the inhibitor iodoacetamide at
5 mM completely inhibited the activity of Ov-AEP-1 (not shown).
e56 T. Laha et al.the same as that of the native protein in ES products and
resulted in reduced proteolytic activity.
Asparaginyl endopeptidase expressed in the
parasite gut and in eggs
The anatomical site ofOv-AEP-1 expression within sections of
adult O. viverrini was investigated by immunolocalizationFigure 7 Immunohistochemical localization of legumain in Opist
strongly to the gut (panel A) and eggs in the uterus (panel B). Control I
same structures (panels C and D). Scale bar are shown.with purified anti-rAEP-1 IgG. Intense staining was observed
in the gut of the adult fluke and also in eggs within the uterus
of the parasite (Figure 7, A and B). Control sections probed
with pre-immunization IgG showed negligible staining
(Figure 7, C and D).
Ov-AEP-1 may be serodiagnostic for human
opisthorchiasis
An immunoblot assay was employed to investigate the poten-
tial of rAEP-1 for serodiagnosis of human opisthorchiasis. The
purified recombinant protein of 47 kDa was recognized by
sera from 64 of 75 persons with parasitologically proven O.
viverrini infection, i.e., stool positive for O. viverrini eggs
(Figure 8A). By contrast, sera from persons confirmed to be
stool-negative for O. viverrini eggs but positive for other
gastrointestinal helminths (hookworm, minute intestinal
fluke, Echinostoma, Taenia) and non-parasitized individuals
did not recognize rAEP-1 (Figure 8B). The sensitivity and the
specificity of the test therefore were 85% and 100%, respec-
tively. The positive predictive value was 100% and the nega-
tive predictive value was 67%.
Discussion
A full-length mRNA transcript encoding Ov-AEP-1 was iso-
lated from adult O. viverrini liver flukes and shown to encode
a functionally active legumain-like protease. Furthermore,horchis viverrini adult worms. Anti-Ov-AEP-1 rabbit IgG bound
gG from the same rabbit prior to immunization did not bind to the
Figure 8 Immunoblot analysis of recognition of recombinant Ov-AEP-1 by sera from people with parasitologically proven infection
with Opisthorchis viverrini (A). ‘+’ and ‘’ indicate positive or negative scores, respectively, for the presence of a band at 47 kDa
representing recognition of the recombinant antigen. C represents sera pooled from several uninfected control donors. Sera from
patients with other parasitic infections did not recognize recombinant Ov-AEP-1 (B). H = hookworm infection; E = echinostomiasis;
T = Taenia infection; M = minute intestinal fluke infection.
Asparaginyl endopeptidase from Opisthorchis viverrini e57the recombinant enzyme was recognized by serum antibodies
from people infected with this carcinogenic liver fluke.
Legumains, or asparaginyl endopeptidases (AEPs), are
cysteine proteases of MEROPS clan CD, Family C13, that
hydrolyze peptides and proteins on the carboxyl side of
asparagine residues.27 They are often found in lysosomes
of diverse cell types and are involved in a variety of proces-
sing functions, including the trans-processing of other pro-
teins.28 In S. mansoni, SmAE (or Sm32 as it was previously
known) was initially thought to be a hemoglobinase but was
later shown not to possess hemoglobinolytic activity,29 and
instead was a member of the legumain family of proteases,
which was proposed to trans-activate other proteins in the
schistosome gut.12,30 Sajid and colleagues subsequently
demonstrated that SmAE was responsible for processing
the S. mansoni cathepsin B hemoglobinase, SmCB1, in the
gut of the parasite.17 A comprehensive assessment of the
hemoglobinase pathways in S. mansoni using RNA interfer-
ence and chemical inhibitors of different classes of protease
found that silencing of the SmAE mRNA had no effect on
hemoglobin digestion, although there was an effect on diges-
tion of serum albumin.31 The authors suggested that this
might be due to either an effect on trans-processing of
hemoglobinases, or the generation of rare cleavages (at
Asn residues) within albumin, thereby further facilitating
its subsequent digestion by other proteases.31 Recently it
has been shown that SmAE is not essential for cathepsin B1
activation in vivo.18
Two AEPs were recently reported from the giant liver
fluke, Fasciola gigantica, and like the schistosome ortholo-
gue, both were expressed in the intestinal epithelium but
neither was detected in ES products of adult flukes.15 Like
these Fasciola AEPs, Ov-aep-1 was expressed in multiple
developmental stages of O. viverrini, including egg, meta-cercaria, juvenile, and adult stages. Due to difficulty in
obtaining sufficient tissues, we did not assess Ov-aep-1
expression in miracidia and cercaria stages. Unlike the Fas-
ciola AEPs, however,Ov-AEP-1 was detected in ES products of
adult worms, using both specific antibodies and enzymatic
techniques. Moreover, using a proteomics approach, Ov-AEP-
1 is a component of the ES products of adult O. viverrini (J.
Mulvenna and A. Loukas, unpublished). Therefore, most, if
not all stages of O. viverrini express the Ov-aep-1 mRNA,
suggesting it plays essential roles in processing fluke proteins
throughout development. Homologues of schistosome hemo-
globinases including cathepsins B and D have been identified
in O. viverrini,20 and we aim to assess the ability of Ov-AEP-1
to process these other Opisthorchis proteases in trans in
future studies.
Ov-AEP-1 was detected in the digestive tract of adult O.
viverrini, accounting for its presence in ES products. SmAE is
expressed in the gastrodermal epithelial cells of S. mansoni
where erythrocytes are lysed and hemoglobinases act to
digest hemoglobin for nutrient acquisition.32 In the human
lung fluke, Paragonimus westermani, legumain is expressed
in the intestinal epithelium of the adult worm.33 Parasitic
helminths other than trematodes also express AEPs in their
intestines; the blood-feeding nematode that parasitizes
sheep,H. contortus, expresses a legumain on themicrovillar
surface of the intestinal cells of adult worms,16 co-localizing
with the sites of expression of other proteinases involved in
blood-feeding.34 Immunolocalization also showed that Ov-
AEP-1 was detected in the eggs of O. viverrini, supporting
the expression of Ov-aep-1 mRNA in this stage of the life
cycle.
Like SmAE, we predict that Ov-AEP-1 is involved in trans-
processing other fluke proteins, particularly the gut pro-
teases involved in feeding. We did not detect hemoglobino-
e58 T. Laha et al.lytic activity with recombinant Ov-AEP-1 (not shown),
despite detecting catalytic activity against the Z-Ala—Ala—
Asn-aminomethylcoumarin peptide at neutral pH. Moreover,
we did detect potent hemoglobinolytic activity in adult worm
extracts at acidic pH values but not at neutral pH (not shown)
where Ov-AEP-1 is catalytically active. This is in marked
contrast to the ‘hemoglobinase’ sequence from the lung
fluke, P. westermani, where the recombinant protein has
been reported to digest hemoglobin at acid pH (and not
neutral pH).33 Moreover, the P. westermani AEP is apparently
sensitive to the inhibitor of C1 family cysteine proteases,
E64, while other AEPs are generally not affected by this
inhibitor, responding mainly to inhibitors that complex with
free-thiols (http://merops.sanger.ac.uk/index.htm).
Immunodiagnostic methods for opisthorchiasis have been
developed based on several antigens. A monoclonal antibody
specific for an unidentified 89-kDa ES antigen was employed
to detect O. viverrini antigen in the feces of infected people,
with 57% sensitivity and 68% specificity.35 Also, a recombinant
egg shell protein of O. viverrini has been assessed as a
diagnostic antigen by enzyme-linked immunoassay, and pro-
vides 48—82% sensitivity and 91—97% specificity; however,
cross-reactivity with schistosomiasis and fascioliasis occurred
with this antigen.36 In comparison, using rAEP-1 we have
demonstrated higher sensitivity (85%) and specificity (100%)
than these earlier reports, indicating the potential of this
antigen for development of a serodiagnostic test for human
opisthorchiasis. Furthermore, detection of Ov-AEP-1 in the
ES and transcripts of Ov-aep-1 in developmental stages
including eggs, metacercariae, and juveniles indicates that
it may be feasible to develop a coproantibody diagnostic
assay for early and current O. viverrini infection. The poten-
tial of antibody- and antigen-based detection methods for
opisthorchiasis-associated cholangiocarcinoma also has been
established.37,38 In like fashion, if O. viverrini AEP-1 could be
developed as a serodiagnostic tool, it would enhance detec-
tion of O. viverrini-associated cancer and could contribute to
measures aimed at reducing the morbidity and mortality
associated with this infection.
Given a putative role for Ov-AEP-1 in trans-processing of
digestive proteases in the gut of O. viverrini, it presents as a
target for vaccines and drugs against this parasite. By inhi-
biting the activity of this enzyme, one might predict that a
number of downstream pathways dependent on AEP-
mediated processing would be affected, particularly diges-
tion of ingested host proteins. Proteases involved in blood-
feeding show promise as recombinant vaccines for a number
of parasitic helminths,39—42 highlighting the potential of Ov-
AEP-1 and other Opisthorchis proteases as intervention tar-
gets for treatment, control, and/or diagnosis.20,43
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